JB Chemicals & Pharmaceuticals Limited on May 11, 2026, recommended a final dividend of ₹9.30 per equity share for the financial year ended March 31, 2026, following the announcement of its Q4 FY26 financial results. The board approved the payout at its meeting held the same day, as disclosed to NSE after market hours.

Total FY26 Dividend Payout

The ₹9.30 final dividend comes on top of the ₹12.70 interim dividend declared in February 2026, bringing the total dividend for FY26 to ₹22.00 per equity share. At the current market price of ₹2,212.70, this translates to a trailing dividend yield of approximately 0.99%. The total payout represents a significant jump from FY25, when the company paid a combined ₹15.50 per share (₹8.50 interim plus ₹7.00 final), marking a year-on-year increase of 42% in aggregate dividend disbursement.

Dividend History and Trend Analysis

A review of JB Chemicals' dividend history over the past four fiscal years reveals a consistent and rising payout pattern across both interim and final tranches:

While FY23 represented a temporary high in total payouts, the FY26 figure of ₹22.00 per share is the highest combined annual dividend in at least five years, underscoring a renewed upward trajectory in shareholder returns. The interim-to-final ratio also shifted in FY26, with the interim component constituting a larger share of the total payout compared to prior years.

Market Context and Valuation

JBCHEPHARM shares closed at ₹2,212.70 on May 11, 2026, up ₹62.90 or 2.93% on the day, touching a 52-week high of ₹2,224.90 on the same date. The stock has recovered sharply from its 52-week low of ₹1,510.10 recorded on May 9, 2025, implying a 46.5% rally from that trough over the past year.

The stock's current price-to-earnings ratio stands at 45.79x, which is in line with the sector PE of 45.79x, suggesting the market is pricing JBCHEPHARM at par with broader pharmaceutical sector peers with no premium or discount relative to the sector benchmark.

Trading Activity and Delivery Data

On the day of the announcement, the counter saw 5,84,031 shares traded with a delivery percentage of 51.29%. A delivery ratio above 50% generally indicates meaningful investor conviction rather than intraday speculative activity, suggesting that a significant portion of the day's buying interest was from investors taking positional or long-term exposure. The stock's daily volatility stands at 1.55%, and its total market capitalisation is ₹35,526.82 Cr.

Company Background

JB Chemicals & Pharmaceuticals is a mid-cap pharmaceutical company listed across multiple NSE indices including NIFTY PHARMA, NIFTY 500, and NIFTY MIDSMALLCAP 400. The company has a presence in branded generics, contract manufacturing, and over-the-counter products across domestic and international markets.

Investors holding shares on the record date yet to be announced will be eligible for the ₹9.30 final dividend, subject to shareholder approval at the forthcoming Annual General Meeting.